J

Jaroslav Žák

Scripps Research Institute

ORCID: 0000-0002-8135-856X

Publishes on Epigenetics and DNA Methylation, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers. 76 papers and 1.8k citations.

PubIndex Score97Top 3% · mid-careerHow it's scored

🔥#1 Rising Star in Lymphoma Diagnosis and Treatment

76Publications

1.8kTotal Citations

#1in Lymphoma Diagnosis and Treatment

First publication: 2012First senior author: 2025

Epigenetics and DNA Methylation Immune Cell Function and Interaction Cancer Immunotherapy and Biomarkers Renal and related cancers CAR-T cell therapy research

Top publicationsby citations

The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule

Benedict C. S. Cross, Heather P. Harding, Peter J. Bond et al.|Proceedings of the National Academy of Sciences|2012

Cited by 594

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma

Jaroslav Žák, John R. Teijaro, Isaraphorn Pratumchai et al.|Science|2024

Cited by 173

ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1

Yihua Wang, Xin Lü, Fangfang Bu et al.|Nature Cell Biology|2014

Cited by 152

Chronic Obstructive Pulmonary Disease: Official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care

Vladimír Koblížek, Sarka Pracharova, Kateřina Neumannová et al.|Biomedical Papers|2013

Cited by 147

A Code for RanGDP Binding in Ankyrin Repeats Defines a Nuclear Import Pathway

Min Lü, Xin Lü, Jaroslav Žák et al.|Cell|2014

Cited by 84